FOCL trades 252.1% below Wall Street's consensus target of $10.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes FOCL achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 8 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 18, 2026, EDAP TMS S.A. American Depositary Shares (FOCL) has a Wall Street consensus price target of $10.00, based on estimates from 8 covering analysts. With the stock currently trading at $2.84, this represents a potential upside of +252.1%. The company has a market capitalization of $106M.
Analyst price targets range from a low of $10.00 to a high of $10.00, representing a 0% spread in expectations. The median target of $10.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 5 analysts rating the stock as a Buy or Strong Buy,3 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, FOCL trades at a trailing P/E of -3.2x. Analysts expect EPS to grow -0.8% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
AEYEAudioEye, Inc. | $138M | $11.06 | $21.00 | +89.9% | Buy | 10.6x | 7 |
ISRGIntuitive Surgical, Inc. | $152.1B | $430.53 | $485.44 | +12.8% | Buy | 38.3x | 57 |
NVCRNovocure Ltd | $1.3B | $11.14 | $26.00 | +133.4% | Buy | — | 15 |
IRTCiRhythm Technologies, Inc. | $2.9B | $89.67 | $169.63 | +89.2% | Buy | — | 22 |
GKOSGlaukos Corporation | $14.3B | $243.25 | $218.70 | -10.1% | Buy | 360.6x | 25 |
VISTVista Energy, S.A.B. de C.V. | $5.6B | $53.96 | $95.00 | +76.1% | Buy | 5.5x | 6 |
PCVXVaxcyte, Inc. | $8.6B | $59.40 | $122.33 | +105.9% | Buy | — | 11 |
MDTMedtronic plc | $131.4B | $102.32 | $97.73 | -4.5% | Buy | 17.1x | 51 |
BSXBoston Scientific Corporation | $64.0B | $43.03 | $54.65 | +27.0% | Buy | 13.6x | 44 |
SYKStryker Corporation | $121.7B | $317.54 | $354.47 | +11.6% | Buy | 21.4x | 52 |
Quick answers to the most common questions about buying FOCL stock.
The consensus Wall Street price target for FOCL is $10, representing 252.1% upside from the current price of $2.84. With 8 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
FOCL has a consensus rating of "Buy" based on 8 Wall Street analysts. The rating breakdown is predominantly bullish, with 5 Buy/Strong Buy ratings. The consensus 12-month price target of $10 implies 252.1% upside from current levels.
FOCL's current price is $2.84 with a consensus target of $10 (252.1% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $10 for FOCL, while the most conservative target is $10. The consensus of $10 represents the median expectation. These targets typically reflect 12-month expectations.
FOCL is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 3 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month FOCL stock forecast based on 8 Wall Street analysts shows a consensus price target of $10, with estimates ranging from $10 (bear case) to $10 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on FOCL, with a "Buy" consensus rating and $10 price target (252.1% upside). 5 of 8 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
FOCL analyst price targets range from $10 to $10, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $10 consensus represents the middle ground.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.